Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Intranasal Midazolam Discomfort
NCT02396537Completed
- Sponsor
- University of Alabama at Birmingham
- Start
- Jan 2014
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial of lidocaine in procedural pain (2 arms), sponsored by University of Alabama at Birmingham. Primary endpoint: Discomfort With Intranasal Midazolam Administration. Started Jan 2014; status: completed.
02
Drugs
lidocaine
03
Conditions
procedural pain
Beyond the preview
Go deeper on NCT02396537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02396537.